Healthcare Services

Global Cognitive Diagnostics Market Set for Strong Expansion Reaching $17.46 Billion by 2030 at 22.7% CAGR

March 31, 2026March 31, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

What Market Value Is Expected For The Cognitive Diagnostics Market At The End Of The 2026–2030 Forecast Period?

The cognitive diagnostics market has seen substantial expansion in recent years. It is anticipated to increase from $6.25 billion in 2025 to $7.69 billion in 2026, achieving a compound annual growth rate (CAGR) of 23.1%. The growth observed in the historic period stems from the growing prevalence of neurodegenerative disorders, increasing awareness of cognitive health, expansion of diagnostic imaging capabilities, rising adoption of standardized cognitive tests, and growth in neurology specialty clinics.

The cognitive diagnostics market is anticipated to experience substantial growth in the upcoming years. It is projected to expand to $17.46 billion by 2030, achieving a compound annual growth rate (CAGR) of 22.7%. This expansion during the forecast period can be attributed to increased investments in digital diagnostics, a heightened demand for early-stage cognitive disorder detection, the proliferation of home-based cognitive assessment tools, the growing integration of AI in clinical decision support, and an increasing focus on personalized cognitive care. Key trends for the forecast period include the rising use of AI-based cognitive assessment tools, greater adoption of digital cognitive screening platforms, the expanding deployment of neuroimaging analytics, the broadening of remote cognitive testing solutions, and an enhanced emphasis on early disease detection.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=19373&type=smp

What Drivers Are Shaping The Future Growth Of The Cognitive Diagnostics Market?

A projected increase in neurological disorder cases is anticipated to drive expansion in the cognitive diagnostics market in the future. These medical conditions impact the brain, spinal cord, and nervous system, hindering their normal operation and resulting in manifestations like diminished cognitive function, motor skill impairment, and sensory irregularities. The growing occurrence of neurological disorders stems from a higher incidence of age-associated ailments including Alzheimer’s and Parkinson’s disease. Additionally, genetic predispositions, environmental pollutants, psychological stress, poor dietary habits, and inactive lifestyles also play a role in the rising frequency of these conditions. Within the context of neurological diseases, cognitive diagnostics serve to evaluate, identify, and track cognitive deficits, facilitating prompt identification and treatment of diseases such as Alzheimer’s and Parkinson’s. As an illustration, a May 2024 report from the Alzheimer’s Association, a U.S.-based non-profit focused on Alzheimer’s care, support, and research, indicated that individuals in America aged 65 and above diagnosed with Alzheimer’s dementia increased from 6.5 million in 2022 to an estimated 6.9 million by 2024. Consequently, the increasing occurrence of neurological disorders is fueling the expansion of the cognitive diagnostics market.

What Segment Types Make Up The Cognitive Diagnostics Market?

The cognitive diagnostics market covered in this report is segmented –

1) By Diagnosis: Brain Imaging Tests, Laboratory Testing, Mental Status Testing, Rapid Home Screening Tests, Neuropsychological Testing, Electroencephalogram (EEG), Cognitive Function And Behavioral Tests, Neuropsychiatric Inventory Questionnaire (NPI-Q)

2) By Indication: Alzheimer’s Disease, Attention Deficit Or Hyperactivity Disorder, Dementia, Epilepsy-Related Cognitive Dysfunction, Mild Cognitive Impairment, Parkinson’s Disease-Related Cognitive Dysfunction, Stroke-Related Cognitive Dysfunction, Traumatic Brain Injury, Other Indications

3) By End User: Hospitals, Neurology Clinics, Cognitive Behavioral Therapy Centers, Rehabilitation Centers, Academic And Research Institutes, Diagnostic Imaging Centers, Home Care Settings

Subsegments:

1) By Brain Imaging Tests: Magnetic Resonance Imaging (MRI), Positron Emission Tomography (PET), Computed Tomography (CT) Scans, Functional MRI (fMRI), Single-Photon Emission Computed Tomography (SPECT), Magnetoencephalography (MEG)

2) By Laboratory Testing: Blood Biomarkers for Cognitive Disorders, Genetic Testing for Cognitive Impairment, CSF (Cerebrospinal Fluid) Biomarker Tests, Hormonal and Metabolic Testing, Genetic Sequencing for Alzheimer’s Disease

3) By Mental Status Testing: Mini-Mental State Examination (MMSE), Montreal Cognitive Assessment (MoCA), Saint Louis University Mental Status (SLUMS) Exam, Cognitive Assessment Screening Tools

4) By Rapid Home Screening Tests: Self-Administered Cognitive Tests, Mobile App-Based Cognitive Screening, At-Home Memory and Mental Health Tests

5) By Neuropsychological Testing: Cognitive and Behavioral Assessment Batteries, Attention and Memory Function Tests, Executive Function and Problem-Solving Tests, Verbal and Visual Learning Tests

6) By Electroencephalogram (EEG): Resting-State EEG for Cognitive Disorders, Event-Related Potential (ERP) Testing, Quantitative EEG (QEEG) for Brain Mapping, Long-Term EEG Monitoring for Cognitive Disorders

7) By Cognitive Function and Behavioral Tests: Memory Function Tests, Attention and Concentration Tests, Language and Communication Tests, Mood and Behavior Assessments

8) By Neuropsychiatric Inventory Questionnaire (NPI-Q): NPI-Q for Dementia Screening, Behavioral and Psychological Symptoms of Dementia (BPSD) Assessment, NPI-Q for Alzheimer’s Disease and Other Cognitive Disorders, Shortened Versions of NPI-Q for Clinical Settings.

What Key Developments And Trends Are Impacting The Cognitive Diagnostics Market?

Leading companies in the cognitive diagnostics market are concentrating on generating real-time insights into cognitive health through technological advancements in diagnostic tools, particularly neuropsychological testing platforms, to improve the accuracy, efficiency, and completeness of cognitive evaluations. Neuropsychological testing platforms are specialized digital instruments designed to evaluate cognitive functions via standardized tests, covering areas such as memory, attention, and problem-solving skills. For instance, in April 2024, BrainCheck Inc., a US-based digital health company driving positive progress in cognitive health, launched its comprehensive digital cognitive assessment platform at the American Academy of Neurology (AAN) Annual Meeting, demonstrating its advanced tools for cognitive screening, assessment, and care planning. The platform, which includes Assess, Screen, and Plan, furnishes clinicians with a contemporary solution to streamline cognitive health management using mobile, digital technology that ensures accuracy and ease of operation. This innovation aims to elevate the efficiency and quality of care for patients and providers by furnishing nuanced, evidence-based recommendations and thorough care planning.

Who Are The Key Players Driving Competition In The Cognitive Diagnostics Market?

Major companies operating in the cognitive diagnostics market are Cogstate Ltd., Viz.ai, Redcliffe Labs, Mind Maze, Neurocare Group AG, Pathway Genomics, Diadem srl, Cambridge Cognition Ltd., Posit Science Corporation, Anderson Diagnostics & Labs. , Altoida AG, BrainScope Company Inc., Neurotrack Technologies Inc., Cognetivity Neurosciences Ltd., BrainCheck, Cyclops MedTech Pvt Ltd, Twill Inc., CN Diagnostics, Savonix Inc., Cognivue Inc., NeuroCog Trials, Pearson Clinical, Re:Cognition Health, CogniSense, The Neuropsychology Consultants

Read the full cognitive diagnostics market report here:

https://www.thebusinessresearchcompany.com/report/cognitive-diagnostics-global-market-report

Which Geographic Regions Are Influencing Demand In The Cognitive Diagnostics Market?

North America was the largest region in the cognitive diagnostics market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the cognitive diagnostics market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Cognitive Diagnostics Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=19373&type=smp

Browse Through More Reports Similar to the Global Cognitive Diagnostics Market 2026, By The Business Research Company

Behavioral Therapy Global Market Report

https://www.thebusinessresearchcompany.com/report/behavioral-therapy-global-market-report

Behavioral Rehabilitation Global Market Report

https://www.thebusinessresearchcompany.com/report/behavioral-rehabilitation-global-market-report

Behavioral And Mental Health Software Global Market Report

https://www.thebusinessresearchcompany.com/report/behavioral-and-mental-health-software-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795